中国实用妇科与产科杂志2013，Vol.29Issue(3)：192-196,5.
多囊卵巢综合征患者代谢综合征指标分析
Clinical analysis of the indicators for metabolic syndrome in patients with polycystic ovary syndrome
摘要
Abstract
Objective To compare the prevalence of metabolic syndrome (MetS) and its abnormal components in polycystic ovary syndrome (PCOS) women, and analyze the ability of MetS components to predict MetS risk in PCOS patients. Methods A total of 208 PCOS women participated in this study between September 2008 and April 2012. The control group was comprised of 205 women recruited randomly. The analysis was done with PCOS patients who were diagnosed u-sing Rotterdam 2003 criteria. The MetS diagnostic criteria of the International Diabetes Federation (IDF) was used. All of the subjects were examined for anthropometric and biochemical parameters. We compared the incidence of MetS and its components between the two groups, and analyzed the ability of MetS components to predict MetS risk in PCOS patients. Results The prevalence of MetS in PCOS patients was 21. 15% significantly higher than controls. PCOS patients with one or more MetS components were up to 69. 23%. Dyslipidemia was the most important feature of metabolic disorders, subsequently hypertension and impaired fasting glucose. WC coupled with HDL-C or WC coupled with TG gave relatively good predictions of the risk of MetS in Chinese patients with PCOS. Conclusion The early intervention to prevent the occurrence of MetS was required for PCOS patients with WC ≥ 80 cm once dyslipidemia (HDL-C < 1. 29 mmol/L or TG >1.7mmol/L) occurred.关键词
多囊卵巢综合征/代谢综合征/血脂异常Key words
polycystic ovarian syndrome/ metabolic syndrome/ dyslipidemia分类
医药卫生引用本文复制引用
林元,孙艳,何斐,薛晓光,饶东冬,池蓉..多囊卵巢综合征患者代谢综合征指标分析[J].中国实用妇科与产科杂志,2013,29(3):192-196,5.基金项目
卫生部科学研究基金资助项目(WKJ2008-2-58) （WKJ2008-2-58）
福建省临床重点专科建设项目资助(闽财指20121589号) （闽财指20121589号）
